ReviewClinical drug investigation2022

A Developer's Perspective on Clinical Evidence and Benefits for Rituximab Biosimilar Uptake, with a Focus on CT-P10.

Dasom Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.